Reply: Comment on ‘A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'

por Szkandera, J, Pichler, M, Stotz, M, Gerger, A
Publicado 2013

Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer

por Pichler, M, Winter, E, Stotz, M, Eberhard, K, Samonigg, H, Lax, S, Hoefler, G
Publicado 2012

The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer

por Stotz, M, Pichler, M, Absenger, G, Szkandera, J, Arminger, F, Schaberl-Moser, R, Samonigg, H, Stojakovic, T, Gerger, A
Publicado 2014

A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients

por Absenger, G, Szkandera, J, Pichler, M, Stotz, M, Arminger, F, Weissmueller, M, Schaberl-Moser, R, Samonigg, H, Stojakovic, T, Gerger, A
Publicado 2013

Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients

por Szkandera, J, Absenger, G, Liegl-Atzwanger, B, Pichler, M, Stotz, M, Samonigg, H, Glehr, M, Zacherl, M, Stojakovic, T, Gerger, A, Leithner, A
Publicado 2013

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients

por Szkandera, J, Gerger, A, Liegl-Atzwanger, B, Absenger, G, Stotz, M, Samonigg, H, Maurer-Ertl, W, Stojakovic, T, Ploner, F, Leithner, A, Pichler, M
Publicado 2013

Long-term cardiovascular complications in stage I seminoma patients

por Terbuch, A., Posch, F., Annerer, L. M., Bauernhofer, T., Pichler, M., Szkandera, J., Hutterer, G. C., Pummer, K., Partl, R., Kapp, K. S., Stöger, H., Gerger, A., Stotz, M.
Publicado 2017

LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy

por Szkandera, J, Herzog, S, Pichler, M, Stiegelbauer, V, Stotz, M, Schaberl-Moser, R, Samonigg, H, Asslaber, M, Lax, S, Leitner, G, Renner, W, Lenz, H-J, Berghold, A, Gerger, A
Publicado 2015

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer

por Stotz, M, Gerger, A, Eisner, F, Szkandera, J, Loibner, H, L Ress, A, Kornprat, P, A Zoughbi, W, Seggewies, F S, Lackner, C, Stojakovic, T, Samonigg, H, Hoefler, G, Pichler, M
Publicado 2013

Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer

por Stotz, M, Gerger, A, Eisner, F, Szkandera, J, Loibner, H, Ress, A L, Kornprat, P, AlZoughbi, W, Seggewies, F S, Lackner, C, Stojakovic, T, Samonigg, H, Hoefler, G, Pichler, M
Publicado 2013

Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients

por Szkandera, J, Stotz, M, Absenger, G, Stojakovic, T, Samonigg, H, Kornprat, P, Schaberl-Moser, R, AlZoughbi, W, Lackner, C, Ress, A L, Seggewies, F S, Gerger, A, Hoefler, G, Pichler, M
Publicado 2014

Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy

por Mollnar, S., Pondorfer, P., Kasparek, A.-K., Reinisch, S., Moik, F., Stotz, M., Halm, M., Szkandera, J., Terbuch, A., Eisner, F., Gerger, A., Kapp, K. S., Partl, R., Vasicek, S., Weiland, T., Pichler, M., Stöger, H., Thurnher, D., Posch, F.
Publicado 2020